A Study to Assess the Safety and Immunogenicity of a COVID-19 Vaccine Booster in Healthy Adults
A Study to Assess the Safety and Immunogenicity of a COVID-19 Vaccine Booster in Healthy Adults
Active, not recruiting · NCT05389319 · Registry updated 2026-06-15Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study to Assess the Safety and Immunogenicity of a COVID-19 Vaccine Booster in Healthy Adults | COVID-19, Coronaviridae Infections, Infections, Nidovirales infectious disease, Orthocoronavirinae infectious disease, RNA Virus Infections, lung disorder, pneumonia, respiratory system disorder, respiratory tract infectious disorder, viral infectious disease, viral pneumonia | Active, not recruiting | Phase 1 | 2026-06-15 | NCT05389319 |
5 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| FGK Clinical Research GmbH | 4 |
| Staburo GmbH | 2 |
| University Hospital Tuebingen | 123 |
| Viedoc Technologies AB | 2 |
| VisMederi srl | 1 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Bernhard-Nocht-Institut für Tropenmedizin | Hamburg | Germany | 1 |
| University Hospital Tübingen, Institute of Tropical Medicine | Tübingen | Germany | 1 |